# Persistence, Adherence and Clinical Effectiveness of Entecavir in Chronic Hepatitis B Patients

> **NCT01356901** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 230 (actual)

## Conditions studied

- Hepatitis B, Chronic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01356901
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 230 (ACTUAL)
- **Last updated:** 2015-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01356901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01356901, "Persistence, Adherence and Clinical Effectiveness of Entecavir in Chronic Hepatitis B Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01356901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*